Heron Therapeutics
HRTX
#10315
Rank
NZ$93.6 M
Marketcap
NZ$0.49
Share price
-5.67%
Change (1 day)
-75.66%
Change (1 year)

Market capitalization of Heron Therapeutics (HRTX)

Market cap: NZ$93.6 Million

As of November 2026 Heron Therapeutics has a market cap of NZ$93.6 Million. This makes Heron Therapeutics the world's 10315th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Heron Therapeutics from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$93.6 M-76.9%
2025NZ$0.40 B-3.05%
2024NZ$0.41 B3.62%
2023NZ$0.40 B-13.82%
2022NZ$0.46 B-65.64%
2021NZ$1.36 B-49.13%
2020NZ$2.67 B-15%
2019NZ$3.15 B4.23%
2018NZ$3.02 B84.82%
2017NZ$1.63 B120.71%
2016NZ$0.74 B-47.38%
2015NZ$1.40 B275.35%
2014NZ$0.37 B46.99%
2013NZ$0.25 B27.5%
2012NZ$0.20 B239.69%
2011NZ$58.94 M151.07%
2010NZ$23.47 M-66.11%
2009NZ$69.27 M209.37%
2008NZ$22.39 M-64.74%
2007NZ$63.51 M28.39%
2006NZ$49.46 M-12.58%
2005NZ$56.58 M-2.24%
2004NZ$57.88 M-25.59%
2003NZ$77.79 M98.93%
2002NZ$39.1 M-71.51%
2001NZ$0.13 B26.76%
2000NZ$0.10 B-18.18%
1999NZ$0.13 B-35.09%
1998NZ$0.20 B-8.24%
1997NZ$0.22 B12.15%
1996NZ$0.19 B

End of Day market cap according to different sources

On Oct 31st, 2026 the market cap of Heron Therapeutics was reported to be:

NZ$93.6 Million
by Nasdaq info icon info icon
NZ$93.6 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
SurModics
SRDX
NZ$1.09 B 1,065.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
NZ$2.57 B 2,654.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$11.42 B 12,104.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$13.50 B 14,327.35%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
NZ$2.35 B 2,417.24%๐Ÿ‡บ๐Ÿ‡ธ USA